These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature. Iqbal M, Goenka P, Young MF, Thomas E, Borthwick TR. Dig Dis Sci; 1998 Oct; 43(10):2223-6. PubMed ID: 9790457 [No Abstract] [Full Text] [Related]
25. Fatal liver injury associated with clopidogrel. Kastalli S, El Aïdli S, Zaïem A, ben Abdallah H, Daghfous R. Fundam Clin Pharmacol; 2010 Aug; 24(4):433-5. PubMed ID: 19895648 [Abstract] [Full Text] [Related]
26. [Cholestatic hepatitis by ticlopidin]. García Ortega P, José Navarro J, Carvajal A, García del Pozo J. Med Clin (Barc); 2001 Jan 27; 116(3):117. PubMed ID: 11181293 [No Abstract] [Full Text] [Related]
28. Clinico-histopathological characteristics of clopidogrel-induced hepatic injury: case report and review of literature. Höllmüller I, Stadlmann S, Graziadei I, Vogel W. Eur J Gastroenterol Hepatol; 2006 Aug 27; 18(8):931-4. PubMed ID: 16825915 [Abstract] [Full Text] [Related]
29. [Ticlopidine-induced hepatitis. Report of a new case]. Rivera Vaquerizo P, Solís García del Pozo J, Villanueva Hernández P. An Med Interna; 2002 Feb 27; 19(2):99-100. PubMed ID: 11989110 [No Abstract] [Full Text] [Related]
30. [Ticlopidine-induced cholestatic hepatitis. A case report]. López P, Castiella A, Bujanda L, Arenas JI. Rev Esp Enferm Dig; 1995 Oct 27; 87(10):735-7. PubMed ID: 8519541 [Abstract] [Full Text] [Related]
31. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting. Chau TN, Yim KF, Mok NS, Chan WK, Leung VK, Leung MF, Lai ST. Hong Kong Med J; 2005 Oct 27; 11(5):414-6. PubMed ID: 16219965 [Abstract] [Full Text] [Related]
33. Acute hepatitis associated with clopidogrel: a case report and review of the literature. Pisapia R, Abdeddaim A, Mariano A, Rianda A, Vincenzi L, Taibi C, Baiocchini A, Del Nonno F, DʼOffizi G. Am J Ther; 2015 Jan 27; 22(1):e8-e13. PubMed ID: 23846525 [Abstract] [Full Text] [Related]
34. Ticlopidine-induced prolonged cholestasis: a case report. Amaro P, Nunes A, Maçôas F, Ministro P, Baranda J, Cipriano A, Martins I, Rosa A, Pimenta I, Donato A, Freitas D. Eur J Gastroenterol Hepatol; 1999 Jun 27; 11(6):673-6. PubMed ID: 10418941 [Abstract] [Full Text] [Related]
37. Ticlopidine induced cholestatic jaundice. Yim HB, Lieu PK, Choo PW. Singapore Med J; 1997 Mar 27; 38(3):132-3. PubMed ID: 9269384 [Abstract] [Full Text] [Related]
38. [Early hepatopathy induced by ticlopidine]. Blanco JR, Márquez M, Salcedo J, Zabala M. An Med Interna; 2001 Jan 27; 18(1):48-9. PubMed ID: 11387849 [No Abstract] [Full Text] [Related]
39. [Cholestatic hepatitis caused by glybenclamide in a patient with hepatitis C virus]. Pérez-Roldán F, Aguirre A, Bañares R, Casado M, González-Asanza C, Alvarez E, Clemente G. Rev Esp Enferm Dig; 1995 Feb 27; 87(2):174-6. PubMed ID: 7748712 [Abstract] [Full Text] [Related]
40. [Acute hepatitis due to ticlopidine. A report of 12 cases and review of the literature]. Pizarro AE, Andrade RJ, García-Cortés M, Lucena MI, Pérez-Moreno JM, Puertas M, Sánchez-Martínez H, Montero JL, Durán JA, Jiménez M, Ruiz-Montero A, Soto-Conesa MJ, Rodrigo L, de Francisco R, Alcántara R, Camargo R. Rev Neurol; 1995 Feb 27; 33(11):1014-20. PubMed ID: 11785026 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]